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Proteoglycans fill the intercellular space between keratino-
cytes but their structure and function are not well under-
stood. We have identified and partially characterized one 
intercellular proteoglycan on human keratinocytes, for 
which we propose the name epic an (epidermal intercellular 
proteoglycan). Monoclonal antibodies (MoAb) were gener-
ated from a mixture of keratinocyte proteoglycans. One, des-
ignated MoAb 17, identified the core protein of an intercellu-
lar proteoglycan that had an apparent mobility of> 250 kDa 
on Western blots. The core protein itself had an apparent 
mobility of 180 kDa following deglycosylation with tri-
fluoromethanesulfonic acid. Enzymatic deglycosylation re-
vealed that most core protein molecules were substituted 
T he intercellular space between epidermal keratino-cytes contains abundant, histochemically demon-strable acid mucopolysaccharide. This material is com posed of inc om pie tel y characterized gl ycosamino-glycans (GAG) and proteoglycans (PG). The function 
of epidermal GAG and PG is unknown, but work in other systems 
suggests that they are important in tissue hydration, growth, and 
morphogenisis (for reviews see [1-3]). A clearer biochemical pic-
ture of cell surface PG on keratinocytes should lead to a better 
understanding of their role in regulating cellular and molecular 
interactions in the epidermis. 
Keratinocytes are capable of synthesizing a variety of GAG, 
which, with the exception of hyaluronate, are attached to proteins 
[4 - 9] . Yet, histochemical studies show that, to a certain extent, 
different GAG are localized to different strata of the epidermis. 
Hyaluronic acid is found predominantly in the intercellular spaces 
of lower layers of the epidermis [10], keratan sulfate is found in the 
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Abbreviations: 
DMEM: Dulhecco's modified Eagle's medium 
ELISA: enzyme-linked immunosorbent assay 
GAG: glycosaminoglycan(s) 
MoAb: monoclonal antibody 
PG: proteoglycan(s) 
35S_PG: [35S] sulfate-labeled proteoglycans 
TBS: Tris-buffered saline 
TFMS: trifluoromethanesulfonic acid 
with heparan sulfate but that some carried chondroitin sul-
fate instead. Smaller forms of the core protein were more 
abundant in tissue-culture medium than in cell extracts. This 
proteoglycan was localized by immunofluorescence to the 
intercellular space of the epidermis and the surface of kerati-
nocytes in vitro, particularly at cell-cell contacts. MoAb17 
did not react with proteoglycans extracted from other skin 
cells, nor did it bind to basement membranes or connective 
tissue. Comparison of Western immunoblots using MoAb 17 
and antibodies to core proteins of other proteoglycans sug-
gested that epican is not related to syndecan but is a member 
of the CD44 family.] Invest Dermatol 99:374-380, 1992 
upper layers of the epidermis [11], and heparan sulfate is found 
throughout the epidermis [12]. 
Core proteins for several PG have been detected on the surface of 
keratinocytes by immunohistochemistry. Antibodies that recognize 
the core proteins of syndecan [13], CD44 [14], and biglycan [15] 
bind to the intercellular space in the epidermis. Each of these core 
proteins had been isolated originally from other cell types and sub-
sequently demonstrated on keratinocytes. 
We have taken a different approach to the analysis of intercellular 
acid mucopolysaccharides in order to identify PG that might be 
specific to keratinocytes. We isolated a crude preparation of kera-
tinocyte PG and used it to raise monoclonal antibodies. One of our 
antibodies recognized the core protein of a new PG localized to the 
intercellular space throughout the epidermis. The partial character-
ization of this PG is described in this paper. 
MATERIALS AND METHODS 
Materials Proteus vulgaris chondroitin ABC lyase, Flavobacterium 
heparinum heparitinase, and (3sS]Na2S04 (carrier free) were ob-
tained from ICN Biomedicals, Costa Mesa, CA. Flavobacterium me-
mingoseptum N-glycosidase F, rabbit antimouse IgG-urease, goat 
anti mouse IgG-peroxidase and IgG-fluorescein isothiocyanate 
(FITC) were products of Boehringer Mannheim Biochemicals, In-
dianapolis, IN. Dulbecco's modified Eagle's medium, fetal bovine 
serum, penicillin, and streptomycin were from Gibco, Grand Island, 
NY. Epidermal growth factor and hydrocortisone were from Col-
laborative Research, Bedford, MA. Trifluoromethanesulfonic acid 
and other chemicals were obtained from Sigma, St. Louis, MO. 
MoAb Fs8-2E9 was the gift of Dr. Guido David, University of 
Leuven, Belgium. Hermes-3 antibody was generously provided by 
Dr. Eugene Butcher, Stanford University School of Medicine, CA. 
Cell Culture Keratinocytes from human neonatal foreskins were 
grown on irradiated or mitomycin C-treated 3T3 cells as 
previously described [16]. Primary cultures were maintained in 
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Dulbecco's modified Eagle's medium (DMEM) supplemented with 
20% fetal calf serum, hydrocortisone (0.4 ,ug/ml), epidermal 
growth factor (10 ng/ml), cholera toxin (100 pM), penicillin (100 
U Iml), and streptomycin (100 ,ug/ml). Epidermal growth factor 
and cholera toxin were removed when the cells became confluent. 
Initially seeded at about 2 X 106 cells/100 mm dish, these cultures 
were used after 3 - 4 weeks of growth, at which time they were well 
stratified. Fibroblast cultures were established from human neonatal 
foreskin tissue outgrowths and grown as described by Ham [17]. 
Secondary cultures, initially seeded at 106 cells/l00 mm dish in 
DMEM supplemented with 10% newborn calf serum were used 
upon reaching confluence. Cultures of normal human melanocytes 
provided by Dr. Ruth Halaban were grown as described in the 
literature [18]. 
Extraction ofKeratinocyte PG 35S_PG were isolated and par-
tially purified as described by Yanagashita and Hascall [19]. In a 
representative preparation, 4 X 100 mm dishes of stratified kerati-
nocytes were labeled for 72 h with 100,uCi/ml of (3sS]sulfate in 
DMEM (0.8 mM endogenous sulfate). The medium was removed 
and the cell layer was washed with PBS. Cells were extracted in the 
dish at 4 ° C for 48 h with a solution of 4 M guanadine hydrochlo-
ride containing 100 mM 6-aminohexanoic acid, 10 mM N-ethyl-
maleimide, 10 mM EDTA, 5 mM benzamidine, 1 mM phenyl-
methanesulfonyl fluoride, and 0.5% Triton X-l 00. The extract was 
collected and each dish rinsed with an additional 2 ml of guanidine 
buffer. Combined extracts were centrifuged at 20,000 X g for 20 
min, and the pellet discarded. Some cultures were labeled with 50 
,uCijmI 3H-glucosamine in addition to sulfate in order to determine 
hyaluronic acid synthesis. 
Chromatographic Separation ofpG 35S_PG in the guanidine 
extract were separated from unincorporated (35S]sulfate and small 
molecules by passage through a G-50 Sephadex column (20 ml bed 
volume). The column was equilibrated and eluted with a buffer of 
8 M urea containing 150 mM NaCI and 50 mM NaOAc (pH 5.8) 
in addition to the same additives that were present in the extraction 
solution. 35S_PG in the void volume were partially purified by ion-
exchange chromatography. Radiolabeled material was applied to an 
8-rnl column ofDEAE-Sephacei (Pharmacia, Piscataway, NJ) equi-
librated with the same urea buffer used in the G-50 column. After 
washing the column with 3 column volumes of this buffer, the PG 
were eluted with a 0.15 -1.50 M NaCI gradient in the same buffer. 
Fifty milliliters of eluate was collected in 1 ml fractions at 3 mljh. 
The distribution of radioactiviry was determined by scintillation-
counting aliquots from each fraction. The concentration of NaCI 
was determined by comparing conductivity measurements of each 
fraction to a standard curve of NaCI in elution buffer. The 35S_PG 
eluted at 0.35-0.65 M NaCI. 
PG size was assessed by chromatography on Sepharose 4-B. Par-
tially purified preparations from the DEAE column were rechroma-
tographed on Sephadex G-50 and the void volume eluate was ap-
plied to a 1.5 X 100 cm column ofSepharose 4-B. The column was 
equilibrated and eluted at 9 mljh with a buffer of 4 M guanidine 
hydrochloride, 50 mM Tris HCI, 0.5% Triton X-I00, 50 mM 
Na2 S04 , 100 mM 6-aminohexanoic acid (pH 7.0). Fractions of 
2 rnl were collected and aliquots were quantitated by scintillation 
counting to determine the label profile. 
Enzymatic and Chemical Digestions ofPG Published proce-
dures were used to digest 35S_PG with papain [20], Proteus vulgaris 
chondroitin ABC lyase [21], Flavobacterium heparinum heparatinase 
[22], and nitrous acid [23]. 35S_PG were digested overnight at room 
temperature with 0.2 M NaOH. Flavobacterium memingoseptum N-
gl ycosidase F digestion was performed according to the manufactur-
ers recommendation. TFMS digestion was performed as described 
by Sojar and Bahl [24] . The digested sample, containing no more 
than 20,u1 of trifluoromethanesulfonic acid (TFMS), was diluted on 
ice -with 2 ml of 0.1 % sodium dodecylsulfate (SDS) and concen-
trated in a Centricon concentrator (Amicon, Beverly, MA). After a 
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s~cond round of dil~tion and concentration the sample was lyophi-
lized and dissolved 111 sample buffer for gel electrophoresis. 
Product~on of Monoclonal Antibodies The immunizing anti-
gen consisted of the 35S_PG from the DEAE column. This fraction 
was precipitated with ethanol, resuspended in 20 mM carbonate 
buffer (pH 9.6), and emulsified with Freund's complete adjuvant 
for the initial injection. PG was emulsified with Freund's incom-
plete adjuvant for booster injections (2 X 2 weeks). Each injection 
contained PG from approximately one 75-cm2 dish of stratified 
keratinocytes. Fo~r BALB/C and four CD2F1 mice were injected 
subcutaneously With thiS proteoglycan preparation. Sera from these 
animals was screened by immunofluorescence and enzyme-linked 
immunosorbent assay (ELISA). Two CD2F1 mice produced the 
highest titer polyclonal antibodies by ELISA that also stained both 
basal lamina and cell membranes of keratinocytes. These mice were 
booste~ intravenously with adjuvant-free PG preparation 3 d prior 
to sacnfice. The spleen cells were fused with Ag 8 myeloma cells 
and cloned. Approximately 1200 clones were screened and four 
were selected and recloned. Of the four, one showed specificity for 
the basement membrane at the dermal-epidermal junction of the 
skin and three stained the cell membranes of keratinocytes. Five 
subclones of each of these four clones were expanded and frozen. 
ELISA Assay The ELISA used in screening clones was based on 
the pH-induced color change in bromocresol purple when urea was 
hydrolyzed by urease-conjugated rabbit anti-mouse second antibod-
ies. Clones were scored positive if the medium changed color from 
yellow to purple within 10 min. Iso typing of monoclonal antibod-
ies of interest was performed with SBA Clonotyping System 1 
(Southern Biotech Associates, Inc., Birmingham, AL) as described 
in the kit. 
Immunofluorescence Frozen tissue sections (5 ,um) of neonatal 
(foreskin) or adult (leg) skin were fixed by sequential IS-min incu-
bations in methanol and acetone at -20 °C, followed by washing 
2 X 5 min in PBS. Sections were blocked for 90 min with normal 
goat serum followed by incubation for 2 h with hybridoma super-
natant. The second antibody incubation for 2 h was with FITC-Ia-
beled goat anti-mouse IgG. After a final washing in PBS, the section 
was mounted with Immu-mount (Lerner Laboratories, New 
Haven, CT) and observed by epifluorescence using a Zeiss IM-35 
microscope. Neonatal human keratinocytes grown on glass cover 
slips until stratified were processed identically to tissue sections 
except that normal rabbit serum was used for blocking and incuba-
tion with hybridoma supernate was overnight at 4°C. 
Immunodot Assay, SDS-PAGE, and Western Blotting Dot 
blots were performed, with minor modification, as described by 
Jalkanen et al [20] using Zeta probe paper (Bio-Rad Laboratories, 
Richmond, CAl. Aliquots of PG or digests were pipetted into the 
wells of a Minifold I (Schleicher & Schuell, Keene, NH) that con-
tained a moistened piece of Zeta-probe backed by 42 Whatman 
paper. Gentle suction was applied and the sample was rinsed once 
with X 400 ,ul of urea buffer and twice with 50 mM Tris, 200 mM 
NaCI, pH8.0 (TBS) containing 0.2% Tween 20. Zeta-probe was 
blocked overnight with 1.25% nonfat powdered milk in TBS and 
washed 2 X 5 min in TBS-Tween 20. The paper was then incu-
bated with primary antibody for 2 h. After two washes the paper 
was incubated with peroxidase-conjugated goat anti-mouse IgG + 
IgM for 2 h and developed with 60,ug/ml dial11.inobenzidine in 
50 mM Tris, 500 mM NaCI, pH 7.6, containing 0.06% hydrogen 
peroxide. For dot and Western blots, MoAb17 was affinity purified 
and concentrated on a column of Avid AL gel (Bioprobe Interna-
tional, Inc. Tustin, CAl. 
PG were e1ectrophoretically separated on a 4-15% linear gra-
dient SDS-PAGE gel using a discontinuous buffer system [25]. Sam-
ples were prepared by either 80% ethanol precipitation or lyophili-
zation, suspended in SDS sample buffer containing 1 mM 
dithiothreitol, and boiled 5 min. Prestained molecular weight 
markers (Bio-Rad Laboratories) were run for molecular mass esti-
mation. For Western blots, the gel was placed in a Transphor e1ec-
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Figure 1. DEAE-Sephacel separation ofkertinocyte proteoglycans. Radio-
labeled material eluting in the void volume of a G-SO Sephadex column was 
bound to DEAE-Sephacel, and eluted with a NaCI gradient (line) as de-
scribed in Materials and Methods. 
trophoresis unit (Hoefer Scientific Instruments, San Francisco, CA) 
according to the manufacturer's instruction and transferred to Zeta-
probe paper using one-quarter strength Towbin buffer [20,26] at 
100 mAmp for 12 -18 h. Indirect enzyme immunostaining identi-
cal to that described for the dot assay was used to visualize antigens 
recognized by the various antibodies. The location of the 35S_PG on 
the Zeta-probe paper was confirmed by autoradiography. Fluoro-
graphy was performed on gels by immersion in Amplify (Amer-
sham, Napier, IL) for 30 min followed by drying and exposure to 
Kodak X-OMAT AR-15 film at -70°C. 
RESULTS 
Isolation and Preliminary Characterization ofKeratinocyte 
Proteoglycans Human keratinocytes were metabolically labeled 
with 3H-glucosamine and 35S-sulfate. After extraction and chroma-
tography on G-50 Sephadex, the excluded material was purified on 
a column of DEAE Sephacel. T he purification of isotopically la-
beled PG from a typical stratified keratinocyte culture is shown in 
Fig 1. The initial peak, eluting at 0.2 M NaCl, was labeled only 
with 3H-glucosamine, and contained between 30 - 50% of the total 
3H-glucosamine incorporated. This peak was> 98% hyaluronic 
acid, judged by digestion with hyaluronidase followed by rechro-
matography over G-SO (data not shown). The second peak eluted 
between 0.4 and 0.6 M NaCI and was labeled with both isotopes. 
35S_PG contained in the high salt peak from the DEAE column were 
subjected to a variety of chemical and enzymatic digestions and then 
visualized by autoradiography following SDS-PAGE. All of the 
label was associated with GAG: preliminary digestions followed by 
analysis of Sephadex G-50 profiles indicated that approximately 
70% of the label in the 35S_PG was heparan sulfate and 30% was 
chondroitin sulfate (data not shown). The bulk of the 35S_PG mi-
grated with an apparent molecular weight of > 200 kDa, but label 
was found throughout the gel (Fig 2, control lane). Digestion of the 
PG preparation .with papain eliminated much of the label from the 
> 200-kDa region of the gel and resulted in a smear throughout the 
rest of the gel. This indicated that the majority of the GAG in the 
> 200-kDa region were attached to protein. The attached GAG 
chains were also heterogeneous in size. When the 35S_PG were 
treated with alkali, which cleaves the 35S-GAG chains from the core 
protein, all of the sulfate label was shifted into species with apparent 
mobility of < 100 kDa. Heparitinase and nitrous acid removed 
nearly all label from the high - molecular-weight proteoglycan, 
leavingjust trace amounts centered around 150 kDa. N-glycosidase 
F, which digests N -linked sugars, had no apparent effect on the 
35S_PG. Digestion of the 35S_PG with chondroitin ABC lyase had 
littl e discernable effect on the high - molecular-weight material, 
but did remove the material that migrated below 200 kDa (compare 
control and chondroitin ABC lanes). These data indicate that the 
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keratinocyte PG are heterogeneous in size, heparan sulfate is pre-
dominantly on large PG, and the bulk of the keratinocyte PG are 
heparan sulfate PG. 
Generation of MoAb In order to identify subgroups of keratino-
cyte PG that shared a common protein epitope, we immunized mice 
with the PG fraction from the DEAE column. Spleens from CD2F1 
mice that produced the highest titer antibodies were fused with 
myeloma cells and the hybridomas screened as described in Materials 
and Methods. Positive lines were subcloned and rescreened twice by 
both ELISA and immunofluorescence assay. MoAb17, an IgG1Kiso-
type, was selected for further study because of its high titer and its 
localization. 
Localization of the Antigen Recognized by MoAb 17 Immu-
nofluorescence microscopy demonstrated that MoAb 17 bound to a 
surface antigen on keratinocytes both in vivo (Fig 3a) and in vitro 
(Fig 3b). In tissue sections of skin, MoAb 17 bound to the intercellu-
lar space between epidermal keratinocytes from the basal layer 
through the stratum granulosum and also outlined epithelial cells in 
sweat glands and hair follicles . It did not react with the epidermal 
surface in contact with the basement membrane, nor did it stain any 
mesenchymal structures in the dermis. MoAb 17 bound to the cell 
surface of cultivated human keratinocytes and showed enllanced 
reactivity in regions of cell-cell contact. In pre-confluent cul.tures, 
MoAb 17 preferentially bound to cellular microprojections (data not 
shown), which are thought to represent focal adhesions [27]. 
Characterization of the PG Recognized by MoAb17 The 
size of the antigen recognized by MoAb 17 was examined by gel 
permeation chromatography and SDS-PAGE. The 35S_PG fraction 
from the DEAE column was further fractionated by Sepharose 4B 
chromatography and aliquots were then tested for reactivity with 
MoAb17. Figure 4 shows that PG eluting from the 4B column were 
a heterogeneous mixture consisting of a broad peak of Kav = 0.38 
and a smaller trailing peak ofKav = 0.86. Immunodot blots showed 
that only fractions from the first large peak off the 4B column 
contained material that bound MoAb17. Thus, the antigen recog-
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Figure 2. Digestion and autoradiography of human keratinocyte 3SS_pro_ 
teoglycans. Equivalent amounts (cpm) of 3sS-proteoglycans were digested 
and separated on SDS-PAGE and autoradiography performed as described in 
Materials and Methods. Lams: control, undigested; PNGase F, N-glycosidase 
F; Chond. ABC, chondroitin ABC lyase; heparitinase; papain; 0.25 M ni-
trous acid; 0.2 M sodium hydroxide. 
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Figure 3. Distribution of MoAb17 antigen in hum~n skin and cultured 
keratinocytes. Tissues and cells were exammed for Immunofluorescence 
localization of MoAb 17 as described in Materials atld Methods. (A) In human 
skin the cells of the epidermis are outlined except at the dermal-epidermal 
junction (arrows) , whereas no derma! stai~ing is observed. (B) In stratified 
keratinocyte cultures the cell surface IS stamed, particularly at cell-cell Junc-
tions . Bars, 50 11m. 
nized by MoAb 17 co-migrated with large PG on size-exclusion 
columns. 
Analysis of PG by Western blotting demonstrated that the epi-
tope recognized by MoAb17 was the core prote111 of a PG. Western 
blots were performed on chemical and enzymatic digests of the 
keratinocyte PG fraction from a DEAE column. In the untreat~d PG 
fraction, MoAb 17 reacted with a broad band of matenal hav111g an 
apparent mobility of> 200 kDa (Fig SA) . Digestion of the PG 
fraction with heparitinase prior to analysIs sharpened the ~and and 
increased its mobility to approximately 200 kDa. Dlgestlon with 
chondroitin ABC lyase did not change the mobility of the bulk of 
the> 200-kDa material that reacted with MoAb 17, but did result in 
the appearance of a band that has the same mobility as that ~enerated 
by heparitinase treatment. The intensity of the c~ondrOlt111 ~C 
lyase - generated band varied b~tween PG preparatIOns, perhaps 111-
dicating differences 111 the 111d.lVld~al cultures from wh~ch the PG 
preparations were derive~. Dlges.tlon with bot.h hepant111ase a~d 
chondroitin ABC lyase (Fig SA) did not further 111crease the mobil-
ity of the band produced by digestion with hepa~itinase alon.e. 
Complete deglycosylation of the keratinocyte p~ with TFMS (Fig 
5B) resulted in a major band of lS0 kDa and vanable amounts of at 
least three smaller bands of 160 kDa, 150 kDa, and 120 kDa. The 
particular preparation show~ in Fig 5B was chosen for demonstra-
tion purposes because all species can be clearly seen. In .most prepara-
tions, however, the lS0-kDa peak was far more prom111ent than the 
other three. 
Several PG have been previously demonstrated on keratinocytes 
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Figure 4. Size distribution of keratinocyte proteoglycans. 3sS-proteogly_ 
cans were separated on Sepharose 4B as described in Materials atld Methods and 
radioactivity was measured in aliquots of each fraction. Groups of four 
fractions were concentrated, spotted onto Zeta-probe, and reacted with 
MoAb 17 as shown on the strip above the radioactivity profile. Heavy litle, 
those fractions positive on the dot blots. 
[13 -15]. Syndecan and CD44 are the two with properties most 
similar to the PG described here and for which antibodies are avail-
able. F5S-2E9 recognizes the core protein of human syndecan* as 
well as a second protein in fibroblasts [2S] and Hermes-3 recognizes 
the core protein of all forms of CD44. On Western blots of undi-
gested keratinocyte PG, Hermes-3 and F5S-2E9 produced a broad 
smear running from the top of the gel to the region around 100 kDa 
(data not shown), whereas MoAb17 recognized only those species 
> 200 kDa (see Fig 5). After partial deglycosylation with heparitin-
ase and chondroitin ABC lyase, each antibody detected a distinct 
pattern of proteins on the Western blot (Fig 6): MoAb 17 detected 
the previously described 200-kDa band; F5S-2E9 detected bands at 
65 kDa and 135 kDa; Hermes-3 detected an SO-kDa band and a 
broad region from 150 to 220 kDa that overlapped the band de-
tected by MoAb 17. Thus MoAb 1 7 appears to recognize a subset of 
the proteins detected by Hermes-3 . 
Both Hermes-3 and F5S-2E9 recognize epitopes on fibroblastic 
as well as epithelial cells, whereas MoAb 17 appears to detect an 
epitope present only on epithelial cells in the skin (see Fig 3). Be-
cause PG epitopes are sometimes masked in tissue sections [15], we 
used an immunodot assay to screen for PG in conditioned medium 
and cell extracts from cultures of keratinocytes, dermal fibroblasts , 
and melanocytes (Fig 7). MoAb17 reacted with cell extracts and 
medium from keratinocytes but not from fibroblasts or melano-
cytes. F5S-2E9 reacted with extracts from keratinocytes and fibro-
blasts and perhaps melanocytes; it reacted with medium from kerati-
nocytes but not from melanocytes or fibroblasts. Hermes-3 reacted 
with extracts and medium from all three cell types. Thus, the epi-
tope recognized by MoAb 1 7 is expressed by fewer cell types than 
those recognized by F5S-2E9 or Hermes-3. 
Western blots were performed on the secreted PG from keratino-
cytes to determine whether they were the same as the cell-associated 
PG recognized by MoAb 17. In undigested samples from condi-
tioned medium, MoAb17 reacted with PG that had essentially the 
Same mobility (> 220 kDa) as PG extracted from the cells. Follow-
ing digestion with heparitinase and chondroitin ABC lyase, how-
ever, proteins of smaller size were found in the medium PG (150 
kDa and lS0 kDa) compared to the cell-associated PG (200 kDa) 
(data not shown) . 
* Dr. Guido David (personal communication) . 
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Figure 5. Immunoblots of digested keratinocyte proteoglycans. (A) West-
ern blots were performed with MoAb 17 as described inMaterials and Methods. 
Equivalent amounts (cpm) of 35S-protcoglycans from a single preparation 
were digested and separated by SOS-PAGE. Latles: control, undigested prote-
oglycan; heparitinase; Chond. ABC, chondroitin ABC lyase; Hep.+ Chond. 
ABC, heparitinase plus chondroitin ABC lyase. (B) Western blot usmg 
MoAb 17 on a TFMS digest of a different proteoglycan preparation than in 
Fig 4 clearly demonstrates the four distinct bands at 180, 160, 150, and 120 
kOa. Molecular weight markers are on the left of both panels. 
DISCUSSION 
We have identified a keratinocyte PG that has a predominant core 
protein of 180 kDa an~ carries either heparan sulfate ?r chondroit~n 
sulfate GAG chains. It 1S found on the surface ofkeratmocytes and m 
the intercellular space between keratinocytes in the epidermis. It is 
not found at the basement membrane nor on non-epithelial cells in 
the skin. There is an epitope on its core protein, recognized by 
MoAb 17, that appears to be shared by some forms of CD44. Because 
of its limited and localized expression, we propose the name epican 
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Figure 6. Immunoblots of Core proteins recognized by antibodies MoAb17, 
F58-2E9, and Hermes-3. Keratinocyte proteoglycans were digested with 
both heparitinase and chondroitin ABC lyase, separated by SOS-PAGE, and 
Western blotted with MoAb17 and F58-2E9 which recognizes human syn-
decan, and Hermes-3, which recognizes C044. 
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Figure 7. Immunodot blots using MoAb17, F58-2E9, and Hermes-3 on 
proteoglycans extracted from several human skin cells. Proteoglycans were 
prepared and partially purified from keratinocytes, melanocytes and dermal 
fibroblasts, and conditioned medium from each cell type. Equivalent 
amounts of proteoglycan (cpm) were spotted onto paper strips and probed 
with each antibody as described in Materials and Methods. (a) represents the 
cell extract and (b) represents the medium in each case. 
(epidermal intercellular proteoglycan) for the .PG recognized by 
MoAb17. 
Keratinocyte PG are heterogeneous in size, as demonstrated in 
the results above and in the literature [8,9]. SDS-P AGE separation 
of 35S_PG from keratinocytes confirmed the size heterogeneity of 
intact PG and of free GAG chains. The molecular weight estimates 
of keratinocyte PG from SDS-PAGE are considerably larger than 
those derived from molecular sieve chromatography [8,9]. N onethe-
less, they should be comparable to published size estimates of other 
PG that were based on mobility in SDS-P AGE. 
We raised MoAb that allowed us to identify a limited set of PG 
that were found in the intercellular space and that shared a common 
core protein. As expected, some of our MoAb, of which MoAb 17 is 
the best example, localized to the intercellular space between kerati-
nocytes; others localized to the basement membrane region of the 
epidermis (unpublished data). . 
Epican has two features that distinguish it from previously de-
scribed keratinocyte PG [13 -15]. First, the majority of molecules 
contains heparan sulfate but a small proportion contains chondroi-
tin sulfate. Either heparitinase or chondroitin ABC lyase alone or 
both together generate the same 200-kDa core, indicating an ei-
ther/ or attachment of GAG chains. These data do not eliminate the 
possibility that both GAG are attached to the same core, but indicate 
that the chains of the minor component would be so short that their 
removal would have no effect on apparent molecular weight. Be-
taglycan, the type III TGF-p receptor, has an either/or attachment 
of GAG chains [29,30], but most PG have only one type of GAG 
chain [31]. Syndecan is a composite PG with two types of GAG 
chain [32,33], whereas the previously described PG form of CD44 
contains chondroitin sulfate [34]. Second, the predominant core 
protein recognized by MoAb 17 is 180 kDa (200 kDa when enzy-
matically deglycosylated) and is larger than previously described 
keratinocyte PG core proteins. For example, deglycosylated synde-
can migrates at about 67 kDa [33] and a deglycosylated form of 
CD44 from keratinocytes migrates at 90-135 kDa [35]. 
To further confirm the distinct identity of epican, we used anti-
bodies to the core proteins of syndecan and CD44 to compare it to 
those PG families. F58-2E9, an antibody that recognizes human 
syndecan, detected different bands than MoAb 17 in keratinocyte 
PG that had been partially deglycosylated with heparitinase and 
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chondroitin ABC lyase. Hermes-3, an antibody that recognizes 
CD44, stained a broad band that overlapped the region of the gel 
stained by MoAb 17 and also a prominent band at 80 kDa. Thus, 
these data indicate that the 200-kDa core is very probably a member 
of the CD44 family. 
Very recently, several groups have used the polymerase chain 
reaction to demonstrate that CD44 is the parent of a large family of 
rnolecules [35,36]. One variant, with a larger than usual CD44 core 
protein, has been associated with heparan sulfate PG o~ ker~ti~o­
cytes [35] . However, lack of an antibody capab!e of dlstlI?-gu~shmg 
that variant from other forms of CD44 made tissue localizatIOn of 
the definitive identity of its attached GAG chains impossible. Other 
variants, some closely related to a metastasis-inducing form of 
CD44 from the rat [37]' have been identified on human carcinoma 
cell lines, including those derived from keratinocytes [36] . It is 
unknown if these forms are expressed as PG. In the following article 
[38] we show that the variant CD44 core protein identified in a 
keratinocyte cDNA expressIOn library by MoAb17 has a nearly 
identical sequence to a CD44 variant previously i~entified by the 
polymerase chain reaction in squamous cell c~rcmoma. m~.NA. 
Thus, MoAb17 identifies the largest CD44 variant, which IS ex-
pressed as a PG in normal human keratinocytes. . 
Three smaller core proteins are detected m varymg amounts by 
MoAb 17 in fully deglycosylated keratinocyte PG preparations. 
post-extraction proteolysis is a possible but unlikely explanation for 
the multiple bands, because several protease inhibitors are pr~se~t 
throughout the isolation procedure. The smaller bands could mdl-
cate proteolytic processing, as has been demonstrated for syndecan 
[39], or distinct products of transcription, as has been suggested for 
the rnembrane-bound and soluble forms of beta glycan [30] . These 
possibili~ie~ could, in turn, ?e related to the pr?gram ofkera.tinocyte 
differentiatIOn. The keratmocyte PG used m these studies were 
derived from stratified cultures, containing proliferating cells as 
well as differentiating cells. If expression and processing of the PG 
were regulated by the program of differentiation, heterogeneity of 
the core protein might result from analyzing a heterogeneous popu-
lation of cells. Experiments in progress should demonstrate which 
of these alternatives is correct. 
The function of epican or other variant forms of CD44 in the 
epidermis is unknown. The ability of PC, in ~eneral, to interact 
with other molecules accounts for the presumptIOn that they serve a 
variety of adhesive functions (for reviews see [1,2]). Binding inter-
actions occur both through the GAG chains and through the core 
protein. These interactions are ~ikely ~odified by the GAG substi-
tution pattern or by the expressIOn of different domams m the core 
protein. For example, the binding of CD44 to hyaluronic acid is 
rnodulated by conversion to CD44(E), which has a larger extracel-
I ular protein domain [40] . Investigations into the function of variant 
forms of CD44 in the epidermis should be facilitated by MoAb 17. 
We thank Lylllie Hough-Marl roe for excellent tec/mical assistance arid Janet Fears for 
manuscript preparatiotl. 
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